OPEN END TURBO LONG - ABBOTT LABORATORIES Stock

Certificat

DE000MC8EYS8

Real-time Bid/Ask 08:59:44 2024-06-04 EDT
1.06 EUR / 1.18 EUR +3.70% Intraday chart for OPEN END TURBO LONG - ABBOTT LABORATORIES
Current month+13.68%
1 month-23.40%
Date Price Change
24-06-04 1.05 -2.78%
24-06-03 1.08 +13.68%
24-05-31 0.95 -3.06%
24-05-30 0.98 +8.89%
24-05-29 0.9 -7.22%

Delayed Quote Börse Stuttgart

Last update June 04, 2024 at 04:28 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN MC8EYS
ISINDE000MC8EYS8
Date issued 2020-04-08
Strike 91.49 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.63
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.52
Lowest since issue 0.3
Spread 0.12
Spread %10.17%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
102.9 USD
Average target price
125.4 USD
Spread / Average Target
+21.88%
Consensus